{"version":"1.0","type":"link","title":"Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.","author_name":"Cognetti DM 외","author_url":"https://prs-insight.online/author/Cognetti%20DM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169376","thumbnail_width":1200,"thumbnail_height":630}